Enzychem Lifesciences Corporation (KOSDAQ: 183490)
South Korea
· Delayed Price · Currency is KRW
1,469.00
+28.00 (1.94%)
Sep 11, 2024, 10:33 AM KST
Enzychem Lifesciences Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 116,508 | 154,649 | 139,497 | 457,391 | 869,255 | 553,292 | |
Market Cap Growth | 6.04% | 10.86% | -69.50% | -47.38% | 57.11% | -27.13% | |
Enterprise Value | 5,617 | 16,479 | -29,937 | 400,389 | 835,243 | 517,193 | |
Last Close Price | 1456.00 | 1818.00 | 1655.00 | 9150.00 | 13885.04 | 9274.26 | |
PE Ratio | - | -16.53 | -5.23 | -17.16 | -38.67 | -26.47 | |
PS Ratio | 1.45 | 2.03 | 5.24 | 19.91 | 33.67 | 17.58 | |
PB Ratio | 0.65 | 0.79 | 0.69 | 6.13 | 11.99 | 7.47 | |
P/FCF Ratio | -18.09 | -12.37 | -6.26 | -18.74 | -51.57 | -30.86 | |
P/OCF Ratio | -21.71 | -15.08 | -9.74 | -24.61 | -62.00 | -36.65 | |
EV/Sales Ratio | 0.07 | 0.22 | -1.12 | 17.43 | 32.35 | 16.44 | |
EV/EBITDA Ratio | -4.57 | -1.47 | 2.44 | -21.48 | -48.93 | -35.78 | |
EV/EBIT Ratio | -3.39 | -1.12 | 2.04 | -19.29 | -43.71 | -31.53 | |
EV/FCF Ratio | -0.61 | -1.32 | 1.34 | -16.40 | -49.55 | -28.85 | |
Debt / Equity Ratio | 0.02 | 0.03 | 0.19 | 0.70 | 0.59 | 0.04 | |
Debt / FCF Ratio | -0.46 | -0.45 | -1.70 | -2.13 | -2.55 | -0.17 | |
Asset Turnover | 0.41 | 0.33 | 0.14 | 0.18 | 0.25 | 0.41 | |
Inventory Turnover | 5.51 | 5.80 | 2.67 | 2.59 | 2.82 | 3.85 | |
Quick Ratio | 11.64 | 10.63 | 4.79 | 1.87 | 9.72 | 7.29 | |
Current Ratio | 14.43 | 12.33 | 5.21 | 2.05 | 10.73 | 8.43 | |
Return on Equity (ROE) | -4.71% | -4.74% | -18.16% | -37.87% | -23.90% | -25.41% | |
Return on Assets (ROA) | -4.16% | -4.01% | -4.81% | -10.10% | -11.44% | -13.49% | |
Return on Capital (ROIC) | -4.37% | -4.19% | -5.01% | -10.71% | -12.40% | -14.66% | |
Earnings Yield | -7.28% | -6.03% | -17.99% | -6.09% | -2.01% | -3.05% | |
FCF Yield | -7.94% | -8.09% | -15.97% | -5.34% | -1.94% | -3.24% | |
Buyback Yield / Dilution | 26.94% | -7.75% | -56.10% | -3.93% | -3.53% | -3.34% | |
Total Shareholder Return | 26.94% | -7.75% | -56.10% | -3.93% | -3.53% | -3.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.